ATRYS HEALTH S.A.  EO-,01
ATRYS HEALTH S.A. EO-,01
Share · ES0105148003 (XMAD)
Overview
No Price
Closing Price XMAD 09.12.2025: 2,71 EUR
12.12.2025 14:29
Current Prices from ATRYS HEALTH S.A. EO-,01
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
A2T.F
EUR
12.12.2025 14:29
2,59 EUR
0,02 EUR
+0,78 %
XDQU: Quotrix
Quotrix
AHSAAP03.DUSD
EUR
12.12.2025 06:27
2,71 EUR
0,14 EUR
+5,45 %
XDUS: Düsseldorf
Düsseldorf
AHSAAP03.DUSB
EUR
11.12.2025 18:31
2,44 EUR
-0,15 EUR
-5,79 %
XMAD: Madrid
Madrid
ATRY.MC
EUR
09.12.2025 08:00
2,71 EUR
-0,01 EUR
-0,37 %
Share Float & Liquidity
Free Float 54,99 %
Shares Float 41,75 M
Shares Outstanding 75,92 M
Company Profile for ATRYS HEALTH S.A. EO-,01 Share
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
Get up to date insights from finAgent about ATRYS HEALTH S.A. EO-,01

Company Data

Name ATRYS HEALTH S.A. EO-,01
Company Atrys Health, S.A.
Website https://www.atryshealth.com
Primary Exchange XMAD Madrid
ISIN ES0105148003
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Marian Isach
Market Capitalization 208 Mio
Country Spain
Currency EUR
Employees 1,6 T
Address Calle VelAzquez, 24, 28001 Madrid
IPO Date 2016-07-22

Ticker Symbols

Name Symbol
Düsseldorf AHSAAP03.DUSB
Frankfurt A2T.F
Madrid ATRY.MC
Quotrix AHSAAP03.DUSD
More Shares
Investors who hold ATRYS HEALTH S.A. EO-,01 also have the following shares in their portfolio:
ANZ NEW ZEALAND (INT'L) LIMITED 3.450% NTS DUE 17/07/2027 (144A)
ANZ NEW ZEALAND (INT'L) LIMITED 3.450% NTS DUE 17/07/2027 (144A) Bond
CELL IMPACT AB
CELL IMPACT AB Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025